Helena Foulkes is EVP & President-CVS Pharmacy of CVS HEALTH Corp. Currently has a direct ownership of 45,107 shares of CVS, which is worth approximately $2.62 Million. The most recent transaction as insider was on Feb 16, 2018, when has been sold 19,965 shares (Common Stock) at a price of $71.04 per share, resulting in proceeds of $1,418,314. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.1K
0% 3M change
0% 12M change
Total Value Held $2.62 Million

Helena Foulkes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2018
SELL
Open market or private sale
$1,418,314 $71.04 p/Share
19,965 Reduced 30.68%
45,107 Common Stock
Feb 16 2018
BUY
Exercise of conversion of derivative security
$899,823 $45.07 p/Share
19,965 Added 23.48%
65,072 Common Stock
Sep 15 2017
SELL
Open market or private sale
$3,221,159 $81.88 p/Share
39,340 Reduced 46.65%
44,996 Common Stock
Sep 15 2017
BUY
Exercise of conversion of derivative security
$2,145,210 $54.53 p/Share
39,340 Added 31.81%
84,336 Common Stock
Jun 26 2017
SELL
Open market or private sale
$1,626,640 $80.0 p/Share
20,333 Reduced 31.12%
44,996 Common Stock
Jun 26 2017
BUY
Exercise of conversion of derivative security
$710,842 $34.96 p/Share
20,333 Added 23.74%
65,329 Common Stock
Jun 19 2017
SELL
Open market or private sale
$1,565,157 $76.98 p/Share
20,332 Reduced 31.12%
44,996 Common Stock
Jun 19 2017
BUY
Exercise of conversion of derivative security
$710,807 $34.96 p/Share
20,332 Added 23.74%
65,328 Common Stock
Apr 03 2017
BUY
Grant, award, or other acquisition
$1,499,965 $78.05 p/Share
19,218 Added 27.29%
51,191 Common Stock (restricted)
Apr 02 2017
SELL
Payment of exercise price or tax liability
$187,929 $78.5 p/Share
2,394 Reduced 5.05%
44,996 Common Stock
Feb 28 2017
BUY
Grant, award, or other acquisition
$1,249,957 $80.58 p/Share
15,512 Added 23.19%
51,388 Stock Unit
Apr 01 2016
SELL
Payment of exercise price or tax liability
$462,361 $104.82 p/Share
4,411 Reduced 8.77%
45,899 Common Stock
Apr 01 2016
BUY
Grant, award, or other acquisition
$999,983 $104.82 p/Share
9,540 Added 20.7%
36,556 Common Stock (restricted)
Feb 29 2016
BUY
Grant, award, or other acquisition
$867,922 $97.17 p/Share
8,932 Added 17.85%
41,109 Common Stock
Jan 02 2016
SELL
Payment of exercise price or tax liability
$72,152 $96.46 p/Share
748 Reduced 2.28%
32,113 Common Stock
Apr 02 2015
SELL
Payment of exercise price or tax liability
$245,888 $102.71 p/Share
2,394 Reduced 7.31%
30,373 Common Stock
Apr 01 2015
BUY
Grant, award, or other acquisition
$874,937 $102.26 p/Share
8,556 Added 16.71%
42,653 Common Stock (restricted)
Feb 27 2015
BUY
Grant, award, or other acquisition
$999,957 $103.87 p/Share
9,627 Added 25.74%
27,775 Common Stock
Nov 07 2014
SELL
Open market or private sale
$4,079,843 $88.07 p/Share
46,325 Reduced 71.93%
18,075 Common Stock
Nov 07 2014
BUY
Exercise of conversion of derivative security
$1,775,637 $38.33 p/Share
46,325 Added 60.59%
30,133 Common Stock
Apr 01 2014
BUY
Grant, award, or other acquisition
$624,927 $74.29 p/Share
8,412 Added 17.71%
39,089 Common Stock (restricted)

Also insider at

HD
HOME DEPOT, INC. Consumer Cyclical
COST
COSTCO WHOLESALE CORP Consumer Defensive
SKIL
Skillsoft Corp. Consumer Defensive
HF

Helena Foulkes

EVP & President-CVS Pharmacy
Atlanta, GA

Track Institutional and Insider Activities on CVS

Follow CVS HEALTH Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

News

Receive news related to CVS HEALTH Corp

Track Activities on CVS